Clinical Trials Browser

Phase 3 × INDUSTRY × Sulindac × Clear all

NCT01483144 2021-06-08

Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)

Phase 3 Completed

171 enrolled 13 charts

Gastrointestinal

Adenomatous Polyposis Coli

NCT01245816 2015-04-24

A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)

Phase 3 Withdrawn

Gastrointestinal

Colonic Polyps, Adenomatous Polyposis Coli